| The role of medical registries, potential applications and limitations B Pop, B Fetica, ML Blaga, AP Trifa, P Achimas-Cadariu, CI Vlad, ... Medicine and pharmacy reports 92 (1), 7, 2019 | 105 | 2019 |
| The role of ketamine in the treatment of chronic cancer pain AO Zgaia, A Irimie, D Sandesc, C Vlad, C Lisencu, A Rogobete, ... Clujul medical 88 (4), 457, 2015 | 54 | 2015 |
| The prognostic value of FOXP3+ T regulatory cells in colorectal cancer C Vlad, P Kubelac, B Fetica, D Vlad, A Irimie, P Achimas-Cadariu J buon 20 (1), 114-9, 2015 | 44 | 2015 |
| Tumor infiltrating lymphocytes as a prognostic factor in malignant melanoma. Review of the literature VA Gata, CI Lisencu, CI Vlad, D Piciu, A Irimie, P Achimas-Cadariu J. BUON 22 (3), 592-598, 2017 | 34 | 2017 |
| Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study … G Oskay-Özcelik, S Alavi, R Richter, M Keller, R Chekerov, SC Cecere, ... Annals of Oncology 29 (4), 910-916, 2018 | 28 | 2018 |
| MiRNA-Based Therapeutics in Oncology, Realities, and O Balacescu, S Visan, O Baldasici, L Balacescu, C Vlad Antisense Therapy, 31, 2019 | 27 | 2019 |
| Gastric cancer: adjuvant chemotherapy versus chemoradiation. A clinical point of view C Cainap, C Vlad, A Seicean, O Balacescu, R Seicean, AM Constantin, ... J BUON 24 (6), 2209-19, 2019 | 27 | 2019 |
| Synthesis and antitumour evaluation of mono-and multinuclear [2+ 1] tricarbonylrhenium (I) complexes D Giffard, E Fischer-Fodor, C Vlad, P Achimas-Cadariu, GS Smith European Journal of Medicinal Chemistry 157, 773-781, 2018 | 26 | 2018 |
| Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies? C Constantinescu, S Pasca, T Tat, P Teodorescu, C Vlad, S Iluta, D Dima, ... Journal for ImmunoTherapy of Cancer 8 (1), e000742, 2020 | 25 | 2020 |
| The role of miRNA-31-3p and miR-31-5p in the anti-EGFR treatment efficacy of wild-type K-RAS metastatic colorectal cancer. Is it really the next best thing in miRNAs D Sur, C Cainap, C Burz, A Havasi, IC Chis, C Vlad, V Milosevic, ... J buon 24 (5), 1739-1746, 2019 | 24 | 2019 |
| GYNOCARE update: modern strategies to improve diagnosis and treatment of rare gynecologic tumors—current challenges and future directions R Di Fiore, S Suleiman, B Ellul, SA O’toole, C Savona-Ventura, A Felix, ... Cancers 13 (3), 493, 2021 | 23 | 2021 |
| Current and new predictors for treatment response in metastatic colorectal cancer. The role of circulating miRNAs as biomarkers A Gherman, L Balacescu, S Gheorghe-Cetean, C Vlad, O Balacescu, ... International journal of molecular sciences 21 (6), 2089, 2020 | 22 | 2020 |
| The role of biomarkers and echocardiography in the evaluation of cardiotoxicity risk in children treated for leukemia D Maniu, C Blag, G Popa, M Bota, C Vlad, C Cainap, O Balacescu, L Pop, ... Morressier, 2017 | 22 | 2017 |
| Indocyanine green use in Urology B Petrut, CE Bujoreanu, D Porav Hodade, VV Hardo, B Ovidiu Coste, ... J buon 26 (1), 266-274, 2021 | 21 | 2021 |
| Current insights into the association of Nestin with tumor angiogenesis. A Onisim, A Achimas-Cadariu, C Vlad, P Kubelac, P Achimas-Cadariu angiogenesis 27 (20), 40, 2015 | 21 | 2015 |
| Evaluation of clinical, morphopathological and therapeutic prognostic factors in rectal cancer. Experience of a tertiary oncology center C Vlad, P Kubelac, D Vlad, A Irimie, P Achimas Cadariu J buon 20 (1), 92-99, 2015 | 21 | 2015 |
| Study of cancer cell cytotoxicity, internalization and modulation of growth factors induced by transferrin-conjugated formulations of metallodrug-functionalized mesoporous … D Díaz-García, E Fischer-Fodor, CI Vlad, JM Méndez-Arriaga, S Prashar, ... Microporous and Mesoporous Materials 323, 111238, 2021 | 18 | 2021 |
| Expression of Nestin and CD133 in serous ovarian carcinoma A Onisim, M Iancu, C Vlad, P Kubelac, B Fetica, A Fulop, ... J buon 21 (5), 1168-1175, 2016 | 17 | 2016 |
| Expression of toll-like receptors in ovarian cancer C Vlad, C Dina, P Kubelac, D Vlad, B Pop, P Achimas Cadariu J BUON 23 (6), 1725-31, 2018 | 16 | 2018 |
| The role of inhibitor of DNA-binding 1 (ID-1) protein and angiogenesis in serous ovarian cancer MP Kubelac, B Fetica, IC VLAD, A Fulop, A Popa, P ACHIMAŞ-CADARIU Anticancer Research 34 (1), 413-416, 2014 | 16 | 2014 |
